USPTO serial 79368676
BREATH BIOPSY OMNI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 10, 2024
- Examiner
- KHAN, AHSEN M
- Law office
- PETITIONS OFFICE
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BREATH BIOPSY OMNI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Feng Shan
Feng Shan SZDC Law PC1629 k Street NW, Suite 300Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded computer software and computer programs to control collection of medical samples and to perform analysis of medical samples in connection with and a part of medical apparatus and instruments; downloadable and recorded computer application software for hand-held computing devices and to perform analysis of medical samples in connection with and as part of medical apparatus and instruments; downloadable and recorded computer software to perform analysis of medical samples in connection with and as part of medical apparatus and instruments; downloadable and recorded medical diagnostic software for use to control collection of medical samples and to perform analysis of medical samples in connection with and as part of medical apparatus and instruments; diagnostic apparatus for detection of disease bio-markers, not for medical purposes; testing apparatus, not for medical purposes, for use to test calibration of spectrometers and gas detectors; chemical detection systems and apparatus, namely, analyzers and sampling equipment in the nature of mass spectrometers for use to diagnose and monitor diseases in connection with and as part of medical apparatus and instruments; particle detectors; spectrometers; pressure sensors; downloadable and recorded computer software and computer programs for medical purposes for use to diagnose and monitor diseases in connection with and as part of medical apparatus and instruments; structural and replacement parts and fittings for all the aforesaid; all of the aforesaid relating to medical diagnosis and medical analysis: none of the foregoing for use in connection with gynaecological apparatus or instruments; none of the foregoing for use in haemodialysis, haemofiltration, haemodiafiltration and plasma therapy. | ACTIVE | — |
| 010 | Medical apparatus and instruments for treating cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; medical diagnostic apparatus for detecting cancer cells; chemical detection systems and apparatus for medical purposes, namely, analyzers and sampling equipment in the nature of sample collection devices used to collect and analyse liquid, solid and gas samples; medical imaging apparatus; medical and clinical devices in the nature of breath samplers, gas collection tubes used for the collection, recording, concentration and analysis of volatile organic compounds in human breath; medical testing kits for home use in the nature of a medical device for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, and fatty liver disease; medical apparatus for the treatment of respiratory conditions; medical diagnostic apparatus for testing, namely, breath detectors for use to detect disease biomarkers; respiratory sensors for medical purposes; spectrometers for medical purposes; structural and replacement parts and fittings for all the aforesaid; none of the foregoing for use in connection with gynaecological apparatus or instruments; none of the foregoing for use in haemodialysis, haemofiltration, haemodiafiltration and plasma therapy | ACTIVE | — |
| 044 | Medical services; consulting services relating to health care; health care; providing advice and information in the field of health; medical care; medical clinic services; health clinic services; medical health assessment services; health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; providing medical information to medical professionals in the form of reports in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; medical testing for diagnostic or treatment purposes; medical diagnostic testing services; testing for disease biomarkers for medical purposes; providing advice, information, and consultancy services relating to the aforesaid; none of the foregoing for use in connection with gynaecological apparatus or instruments; none of the foregoing for use in haemodialysis, haemofiltration, haemodiafiltration and plasma therapy. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Owlstone Medical Limited
- Other trademarks owned by Owlstone Medical Limited
- Other trademarks owned by Owlstone Medical Limited
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named BREATH BIOPSY OMNI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 24, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 23, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 10, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 10, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 10, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2024 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Aug 14, 2024 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 25, 2024 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jul 1, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 25, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 11, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 5, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 12, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 21, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 21, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 8, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 4, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |